Suppr超能文献

用于指导终止腹膜透析的腹膜透析液标志物:日本多中心前瞻性研究

Markers in peritoneal effluent for withdrawal from peritoneal dialysis: multicenter prospective study in Japan.

作者信息

Kawanishi Hideki, Fujimori Akira, Tsuchida Kenji, Takemoto Yoshiaki, Tomo Tadashi, Minakuchi Jun, Yamamoto Tadashi, Kim Masao, Numata Akira, Choh Shisoh, Naito Hidemune

机构信息

Tsuchiya General Hospital, Hiroshima, Japan.

出版信息

Adv Perit Dial. 2005;21:134-8.

Abstract

The most serious problem in peritoneal dialysis (PD) is the risk of final complication by encapsulating peritoneal sclerosis (EPS) because of peritoneal deterioration. Markers useful for the noninvasive evaluation ofperitoneal deterioration are therefore required. In this multicenter prospective study of stable PD patients, we compared the dialysate-to-plasma (D/P) concentration ratios of albumin, immunoglobulin G, and c2-macroglobulin, and effluent levels of interleukin 6 (IL-6) and fibrinogen/fibrin degradation products (FDPs) to clarify the relationship between inflammation, fibrinolysis markers, and permeability to large molecules. At the beginning of the present study, significantly positive correlations were noted between the IL-6 and FDP concentrations and the D/P ratios of albumin and a2-macroglobulin. In addition, a significantly positive correlation was noted between the FDP and IL-6 concentrations. However, the D/P ratio of creatinine obtained by peritoneal equilibration test did not positively correlate with those markers. Moreover, a significantly positive correlation was noted between changes in the effluent concentrations of FDPs and IL-6 and in permeability markers for large molecules. The effluent IL-6 and FDP concentrations reflect a chronic inflammatory state in the peritoneum, which is associated with increased permeability to large molecules. In individual PD patients, careful observation of the clinical course and evaluation of changes in such markers are expected to predict peritoneal deterioration and the development of EPS.

摘要

腹膜透析(PD)最严重的问题是由于腹膜退变导致包裹性腹膜硬化(EPS)最终引发并发症的风险。因此,需要有助于对腹膜退变进行无创评估的标志物。在这项针对稳定的PD患者的多中心前瞻性研究中,我们比较了白蛋白、免疫球蛋白G和α2-巨球蛋白的透析液与血浆(D/P)浓度比,以及白细胞介素6(IL-6)和纤维蛋白原/纤维蛋白降解产物(FDPs)的流出液水平,以阐明炎症、纤溶标志物与大分子通透性之间的关系。在本研究开始时,发现IL-6和FDP浓度与白蛋白和α2-巨球蛋白的D/P比之间存在显著正相关。此外,FDP和IL-6浓度之间也存在显著正相关。然而,通过腹膜平衡试验获得的肌酐D/P比与这些标志物无正相关。此外,FDPs和IL-6流出液浓度的变化与大分子通透性标志物之间存在显著正相关。流出液IL-6和FDP浓度反映了腹膜的慢性炎症状态,这与大分子通透性增加有关。在个体PD患者中,仔细观察临床病程并评估此类标志物的变化有望预测腹膜退变和EPS的发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验